Academic Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Juul, D.
* Articles by Sheiber, S. C.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Juul, D.
* Articles by Sheiber, S. C.
Related Collections
* Education, Psychiatrists
Academic Psychiatry 29:211-214, June 2005
© 2005 Academic Psychiatry


Perspective

Assessment of Psychopharmacology on the American Board of Psychiatry and Neurology Examinations

Dorthea Juul, Ph.D., Daniel K. Winstead, M.D. and Stephen C. Sheiber, M.D.

Drs. Juul and Scheiber are with the American Board of Psychiatry and Neurology, Inc., Deerfield, Illinois. Dr. Winstead is with the Department of Psychiatry and Neurology at Tulane University School of Medicine, New Orleans, Louisiana. Address correspondence to Dr. Juul, ABPN, 500 Lake Cook Rd., Ste. 335, Deerfield, IL 60015; djuul{at}abpn.com (E-mail). Copyright © 2005 Academic Psychiatry.

OBJECTIVE: To report the assessment of psychopharmacology on the certification and recertification exams in general psychiatry and in the subspecialties administered by the American Board of Psychiatry and Neurology (ABPN). METHODS: The ABPN’s core competencies for psychiatrists were reviewed. The number of items addressing psychopharmacology or neuropharmacology was determined for each examination. For the multiple-choice certification exams, item performance was reviewed. The grade cards of failing candidates were reviewed for the oral certification exam. RESULTS: A significant number of the core competencies involved psychopharmacology. The percent of items addressing the topic varied by examination but was substantial in general. Performance on these items on the multiple-choice certification exam was similar to performance in other areas. However, a majority of those who failed the patient section of the oral examination had inadequate performance in the area of drug treatment, indicating that trainees may need additional experience with applying psychopharmacological knowledge in the context of patient cases. CONCLUSION: This review indicated that knowledge of psychopharmacology was a significant component of the ABPN’s core competencies and of its certification and recertification exams.




This article has been cited by other articles:


Home page
Acad. PsychiatryHome page
I. D. Glick, C. Salzman, B. M. Cohen, D. F. Klein, C. Moutier, H. A. Nasrallah, D. Ongur, P. Wang, and S. Zisook
Improving the Pedagogy Associated With the Teaching of Psychopharmacology
Acad Psychiatry, June 1, 2007; 31(3): 211 - 217.
[Abstract] [Full Text] [PDF]


Home page
Acad. PsychiatryHome page
M. D. Jibson
Psychopharmacology Training in Psychiatric Education: The Debate
Acad Psychiatry, June 1, 2005; 29(2): 120 - 123.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2005 Academic Psychiatry. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Association of Chairs of Departments of Psychiatry American Association of Directors of Psychiatric Residency Training Association of Directors of Medical Student Education in Psychiatry Association for Academic Psychiatry
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org